Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane

There is no fulltext present in this item.

Title:	Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Author(s):	Willemsen, A.E.C.A.B. ; Geus-Oei, L.F. de ; Boer, Maaike de; Tol, Jolien ; Kamm, Yvonne; Jong, P.C. de; Jonker, M.A. ; Aarntzen, E.H.J.G. ; Gerritsen, W.R. ; Herpen, C.M.L. van ; Erp, N.P. van
Publication year:	2018
Source:	Targeted Oncology, vol. 13, iss. 5, (2018), pp. 641-648
ISSN:	1776-2596
DOI:	https://doi.org/10.1007/s11523-018-0596-8
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/196902
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization:	Medical Oncology Radiology & Nuclear Medicine Radboudumc Extern Health Evidence Clinical Pharmacy
Journal title:	Targeted Oncology
Volume:	vol. 13
Issue:	iss. 5
Page start:	p. 641
Page end:	p. 648